경도인지장애와 경도치매 단계에서의 한의 변증 및 간 혈액지표 연관성 탐색 연구

키워드

참고문헌 (41)

1. Weidner WS, "P4-443: THE STATE OF THE ART OF DEMENTIA RESEARCH: NEW FRONTIERS", Alzheimer’s & Dementia, 15(7S_Part_28), pp.1473~ (2019)
2. O’Bryant SE, "Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer’s coordinating center database", Arch Neurol, 67, pp.746~749 (2010)
3. McDougall F, "Psychometric properties of the clinical dementia rating-sum of boxes and other cognitive and functional outcomes in a prodromal alzheimer’s disease population", J Prev Alzheimers Dis, 8, pp.151~160 (2021)
4. Thoits T, "Association between dementia severity and recommended lifestyle changes : a retrospective cohort study", Am J Alzheimers Dis Other Demen, 33, pp.242~246 (2018)
5. O’Malley AS, "Disentangling the linkage of primary care features to patient outcomes: a review of current literature, data sources, and measurement needs", J Gen Intern Med, 30(Suppl 3), pp.S576~S585 (2015)
6. Petersen RC, "Clinical practice. Mild cognitive impairment", N Engl J Med, 364, pp.2227~2234 (2011)
7. Shirwaikar A, "Integrating com-plementary and alternative medicine with primary health care", Evid Based Complement Alternat Med, 2013, pp.948308~ (2013)
8. Birch S, "Overview on pattern identification – History, nature and strategies for treating patients : A narrative review", European Journal of Integrative Medicine, 35, pp.101101~ (2020)
9. The Textbook Compilation Committee of Neuropsychiatry of Korean Medical Schools in Nation. Third edition : The Neuropsychiatry of Oriental medicine, "The Neuropsychiatry of Oriental medicine", pp.319~327 (2016), Jipmoon-Dong
10. "Donguibogam" (2007), Namsandang
11. Shi J, "The Pattern element scale : a brief tool of traditional medical subtyping for dementia", Evidence-Based Complementary and Alternative Medicine, 2013, pp.460562~ (2013)
12. 이고은, "한의학 병리적 노화 척도와 치매 한의학적 변증진단 개발 및 신뢰도 평가", 대한한의학회지, 38(3), pp.111~123 (2017), 대한한의학회[DOI]
13. 이지윤, "인지장애 변증평가도구의 신뢰도와 타당도 평가: 임상연구 프로토콜", 동의신경정신과학회지, 29(4), pp.255~266 (2018), 대한한방신경정신과학회[DOI]
14. Cho JH, "A nationwide study of the incidence rate of herb-induced liver injury in Korea", Arch Toxicol, 91, pp.4009~4015 (2017)
15. 김근엽, "장기간 한약 복용한 뇌졸중 환자의 간 및 신장 기능 수치 변화에 대한 증례 보고", 대한한방내과학회지, 38(5), pp.555~563 (2017), 대한한방내과학회
16. Herholz K, "Metabolic regional and network changes in Alzheimer’s disease subtypes", J Cereb Blood Flow Metab, 38, pp.1796~1806 (2018)
17. Fillit H, "Cardiovascular risk factors and dementia", Am J Geriatr Pharmacother, 6, pp.100~118 (2008)
18. Santos CY, "Pathophysiologic relationship between Alzheimer’s disease, cerebrovascular disease, and cardiovascular risk : A review and synthesis", Alzheimers Dement(Amst), 7, pp.69~87 (2017)
19. Le Couteur DG, "The association of alanine transaminase with aging, frailty, and mortality", J Gerontol A Biol Sci Med Sci, 65, pp.712~717 (2010)
20. Lu Y, "Low liver enzymes and risk of dementia : the Atherosclerosis Risk in Communities(ARIC)study", J Alzheimers Dis, 79, pp.1775~1784 (2021)
21. Jeong JH, "Safety and efficacy of Jujadokseo-hwan for memory deficit(amnesia)in mild neurocognitive disorder : A protocol for randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial", Medicine, 99, pp.e19231~ (2020)
22. Hughes CP, "A new clinical scale for the staging of dementia", Br J Psychiatry, 140, pp.566~572 (1982)
23. Lynch CA, "The clinical dementia rating sum of box score in mild dementia", Dement Geriatr Cogn Disord, 21, pp.40~43 (2006)
24. Morris JC, "The Clinical Dementia Rating(CDR) : current version and scoring rules", Neurology, 43, pp.2412~2414 (1993)
25. Miao Y, "Correlation between cognitive functions and syndromes of traditional Chinese medicine in amnestic mild cognitive impairment", Zhong xi yi jie he xue bao= Journal of Chinese Integrative Medicine, 7, pp.205~211 (2009)
26. Miao YC, "Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment : a randomized, double-blind and parallel-controlled trial", Zhong Xi Yi Jie He Xue Bao, 10, pp.390~397 (2012)
27. Liu J, "Recognition of dementia in ancient China", Neurobiology of aging, 33, pp.2948.e11~2948.e13 (2012)
28. Lim HS, "Bojungikgi-Tang, a traditional herbal formula, exerts neuroprotective effects and ameliorates memory impairments in alzheimer’s disease-like experimental models", Nutrients, 10 (2018)
29. Fu C, "Identification and classification of traditional Chinese medicine syndrome types among senior patients with vascular mild cognitive impairment using latent tree analysis", J Integr Med, 15, pp.186~200 (2017)
30. Tang NY, "Chinese medicine patterns in patients with post-stroke dementia", J Tradit Complement Med, 2, pp.123~128 (2012)
31. Tian JZ, "Sequential therapy based on evolvement of patterns : a new model for treatment of alzheimer’s disease", Chin J Integr Med, 25, pp.565~573 (2019)
32. Cummings J, "Exploring the relationship between patient-relevant outcomes and Alzheimer’s disease progression assessed using the clinical dementia rating scale : a systematic literature review", Front Neurol, 17, pp.1208802~ (2023)
33. Bae H, "A novel framework for understanding the pattern identification of traditional asian medicine from the machine learning perspective", Front Med(Lausanne), 8, pp.763533~ (2021)
34. Choi Y, "Korean traditional medicine in treating patients with mild cognitive impairment : a multicenter prospective observational case series", Evidence-Based Complementary and Alternative Medicine, 22, pp.4323989~ (2020)
35. Nho K, "Association of altered liver enzymes with alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers", JAMA Netw Open, 2, pp.e197978~ (2019)
36. Parsons CG, "Glutamate in CNS disorders as a target for drug development : an update", Drug News Perspect, 11, pp.523~569 (1998)
37. Cassano T, "Glutamate and mitochondria : two prominent players in the oxidative stress-induced neurodegeneration", Curr Alzheimer Res, 13, pp.185~197 (2016)
38. Pietzner M, "Hepatic steatosis is associated with adverse molecular signatures in subjects without diabetes", J Clin Endocrinol Metab, 103, pp.3856~3868 (2018)
39. Kapogiannis D, "Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer’s disease", Lancet Neurol, 10, pp.187~198 (2011)
40. Qian K, "Hepatic ALT isoenzymes are elevated in gluconeogenic conditions including diabetes and suppressed by insulin at the protein level", Diabetes Metab Res Rev, 31, pp.562~571 (2015)
41. Wu K, "Association of lower liver function with cognitive impairment in the Shenzhen ageing-related disorder cohort in China", Front Aging Neurosci, 14, pp.1012219~ (2022)

관련 논문AI추천